Cultured arbuscular mycorrhizal fungi and native soil inocula improve seedling development of two pioneer trees in the Andean region

The tree species Alnus acuminata and Morella pubescens, native to South America, are candidates for soil quality improvement and afforestation of degraded areas and may serve as nurse trees for later inter-planting of other trees, including native crop trees. Both species not only form symbioses with arbuscular mycorrhizal fungi (AMF) and ectomycorrhizal fungi (EMF), but also with N₂-fixing actinobacteria. Because tree seedlings inoculated with appropriate mycorrhizal fungi in the nursery resist transplanting stress better than non-mycorrhizal seedlings, we evaluated for A. acuminata and M. pubescens the potential of inoculation with mycorrhizal fungi for obtaining robust tree seedlings. For the first time, a laboratory-produced mixed AMF inoculum was tested in comparison with native soil from stands of both tree species, which contains AMF and EMF. Seedlings of both tree species reacted positively to both types of inocula and showed an increase in height, root collar diameter and above- and belowground biomass production, although mycorrhizal root colonization was rather low in M. pubescens. After 6 months, biomass was significantly higher for all mycorrhizal treatments when compared to control treatments, whereas aboveground biomass was approximately doubled for most treatments. To test whether mycorrhiza formation positively influences plant performance under reduced water supply the experiment was conducted under two irrigation regimes. There was no strong response to different levels of watering. Overall, application of native soil inoculum improved growth most. It contained sufficient AMF propagules but potentially also other soil microorganisms that synergistically enhance plant growth performance. However, the AMF inoculum pot-produced under controlled conditions was an efficient alternative for better management of A. acuminata and M. pubescens in the nursery, which in the future may be combined with defined EMF and Frankia inocula for improved management practices.     

Electronic quantification of traction force during use of a mechanical calving aid in bovine parturition

In this study, a specially developed computer-controlled system was used to obtain a continuous measurement of the forces that arise when using a mechanical calving aid. By this means, potentiograms for twenty-four births in cows using a tractive device were obtained (fourteen primiparae with an average age of twenty-eight months; ten pluriparae with an average age of fifty-four months; breeds: thirteen RB, eleven SB). A modern mechanical calving device with a locking mechanism was used as an aid in the extraction process. In births with use of light tractive force (approx. 50 kp), extraction took between 41 and +/- 21 seconds. Moderately heavy tractive force (approx. 80-100 kp) was applied in extractions taking 86 to +/- 22 seconds, whereas heavy tractive force (etwa 100-120 kp) was used in extractions lasting between 268 and +/- 117 seconds. The highest levels measured for brief applications of force were between 130 and 140 kp. Single strains of up to 150 kp were reached. Injuries in the soft birth canal were ascertained in 29.2% of the births. Such injuries were discerned more often in primiparae than in the pluriparae. The lacerations were merely superficial and caused no further after-effects. There were no limb injuries in the calves. For the use of mechanical calving aids the use of chains with exact markings should ensure that the limbs are fixated at equal lengths. Furthermore, every device should be equipped with a locking mechanism (150 kp) to prevent the use of too much force. This also prevents misjudgment of the birth situation concerning fetus size and the dimensions of the mother cow's pelvis.     

Offspring from non-stimulated calves at an age younger than two months: a preliminary report

This study investigated the viability of embryos from non-stimulated 2-3-month-old calves generated in vitro using oocytes from follicles of defined size in terms of their ability to produce full-term pregnancies. Ablation of follicles>or=4 mm was used to induce the emergence of a new follicular wave, and calves (n=3) were laparoscopically punctured three times at 7-day-intervals to recover cumulus-oocyte-complexes (COCs) from follicles>8 (group A) and between 4-8 mm (group B). Calves were aged 49, 56, and 80 days, respectively, at first recovery. Morphologically intact COCs were subjected to in vitro maturation, fertilization, and embryo culture, and compact morulae/blastocysts were transferred on day 7 post-insemination to synchronized virgin heifers. Blood typing was used for maternity analysis. A total of 29 COCs were recovered, 21 cultured, yielding 11 cleaved embryos (52.4%) and 6 compact morulae/blastocysts (28.6%). No differences were observed between groups. Transfer of the 6 embryos to 5 recipients resulted in three pregnancies (one from group A and two from group B). Two normal male offspring (both from group B), with birth weights of 44 and 51 kg, were born, and two donor calves, aged 56 and 59 days, were identified as the dams. In conclusion, the results demonstrate that embryos generated in vitro from oocytes from non-stimulated calves at an age younger than two months are viable in terms of their ability to produce full-term pregnancies, and suggest that the viability of calf embryos is not related to follicle size.     

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis

Brucellosis is not a sustainable disease in humans. The source of human infection always resides in domestic or wild animal reservoirs. The routes of infection are multiple: food-borne, occupational or recreational, linked to travel and even to bioterrorism. New Brucella strains or species may emerge and existing Brucella species adapt to changing social, cultural, travel and agricultural environment. Brucella melitensis is the most important zoonotic agent, followed by Brucella abortus and Brucella suis. This correlates with the fact that worldwide, the control of bovine brucellosis (due to B. abortus) has been achieved to a greater extent than the control of sheep and goat brucellosis (due to B. melitensis), these latter species being the most important domestic animals in many developing countries. The long duration and high cost of treatment of human brucellosis reduces the efficacy of the therapy. There is no human vaccine for brucellosis and the occurrence of brucellosis is directly linked to the status of animal brucellosis in a region. In this context, the Word Health Organization has defined the development of a human vaccine, besides the implementation of control and eradication programs in animals, as a high priority. The pathogenicity for humans of B. suis biovars 1, 3 and 4 is well established, whereas B. suis biovar 2 seems to be less pathogenic. Indeed, although hunters and pig farmers have repeatably experienced infectious contact with B. suis biovar 2 (found in wild boar and outdoor-rearing pigs in Europe), isolation of B. suis biovar 2 from human samples have only been seldom reported. Marine mammal brucellosis, due to two new proposed Brucella species i.e. B. cetaceae and B. pinnipediae, represents a new zoonotic threat but the pathogenicity for humans of the different Brucella species found in cetaceans and pinnipeds still has to be clearly established.     

谷蛋白对NOD小鼠糖尿病的发生及其肠道菌群影响的研究

动物糖尿病的分类主要根据人类的糖尿病分类.从对胰岛素有无依赖性可分为Ⅰ型糖尿病、Ⅱ型糖尿病和其他类型糖尿病.糖尿病犬大部分是Ⅰ型;猫主要患Ⅱ型糖尿病,Ⅰ型糖尿病相对较少.动物糖尿病的发病主要与老龄化、肥胖、性别及饲养方式等有一定的关系。     

Brucella evolution and taxonomy

The genus Brucella contains alpha-Proteobacteria adapted to intracellular life within cells of a variety of mammals. Controversy has arisen concerning Brucella internal taxonomy, and it has been proposed that the DNA–DNA hybridization-based genomospecies concept be applied to the genus. According to this view, only one species, Brucella melitensis, should be recognized, and the classical species should be considered as biovars (B. melitensis biovar melitensis; B. melitensis biovar abortus; etc.). However, a critical reappraisal of the species concept, a review of the population structure of bacteria and the analysis of Brucella genetic diversity by methods other than DNA–DNA hybridization show that there are no scientific grounds to apply the genomospecies concept to this genus. On the other hand, an enlarged biological species concept allows the definition of Brucella species that are consistent with molecular analyses and support the taxonomical standing of most classical species. Both the host range as a long-recognized biological criterion and the presence of species-specific markers in outer membrane protein genes and in other genes show that B. melitensis, B. abortus, B. ovis, B. canis and B. neotomae are not mere pathovars (or nomenspecies) but biologically meaningful species. The status of B. suis is, however, less clear. These approaches should be useful to define species for the marine mammal Brucella isolates, as illustrated by the grouping of the isolates from pinnipeds or from cetaceans by omp2 gene analysis. It is shown that a correct Brucella species definition is important to understand the evolution of the genus.     

Identification of novel DNA fragments and partial sequence of a genomic island specific of Brucella pinnipedialis

Since the 1990s, Brucella strains have been isolated from a wide variety of marine mammals and were recently recognized as two different species, i.e. Brucella pinnipedialis for pinniped isolates and Brucella ceti for cetacean isolates. The aim of this study was to identify specific DNA fragments of marine mammal Brucella strains using a previously described infrequent restriction site-PCR (IRS-PCR) method but with three new couples of restriction enzymes applied on a larger panel of marine mammal Brucella isolates (n=74) and one human isolate from New Zealand likely from marine mammal origin. This study revealed five DNA fragments specific of Brucella strains isolated from marine mammals. Among them two new DNA fragments were specific of B. pinnipedialis but were not detected in hooded seal isolates. DNA fragment I identified in the previous IRS-PCR study and fragment VI of this study were located on a cloned and sequenced 6kb SacI fragment. Its nucleotide sequence revealed that it is likely part of a putative genomic island. Sequence analysis showed that it carries four ORFs coding for putative metabolic functions. Although hooded seal isolates are classified within B. pinnipedialis it was shown in this study that they do not carry this genomic island and this raises the question about their evolutionary history within B. pinnipedialis.     

Use of a cervical stent for long‐term treatment of pyometra in the mare: A report of three cases

An effective long‐term treatment is necessary for mares with pyometra, because the condition tends to recur. In many affected animals, several conformational or anatomical anomalies contribute to impaired uterine clearance. Ovariohysterectomy is the surgical procedure of choice. Conservative therapy consists of draining and flushing the uterus, and systemic anti‐inflammatory and antimicrobial treatment. Uterine secretions tend to accumulate again after local treatment, especially in mares with poor vaginal conformation or cervical adhesions. Herein, we describe three cases in which a cervical stent was used in mares after mechanical or manual dilation of the cervix to achieve permanent draining of the uterus. The mares remained symptom‐free for up to 6 years and exhibited good clinical progress and good performance in competitions. Potential complications of the procedure include loss of the stent and obstruction caused by viscous secretion. A cervical stent is a relatively easy and low‐cost option for the long‐term treatment of pyometra in mares, particularly in cases where excessive costs of surgery and risks of a general anaesthesia are to be avoided.